Pentoxifylline inhibits hypoxia-induced upregulation of tumor cell tissue factor and vascular endothelial growth factor

Thrombosis and Haemostasis

Volumn 80, Issue 4, 1998, Pages 598-602

  Amirkhosravi, Ali ^a   Meyer, Todd ^a   Warnes, Gary ^a   Amaya, Mildred ^a   Malik, Zaiba ^a   Biggerstaff, John P ^a   Siddiqui, Farooq A ^a   Sherman, Paul ^a   Francis, John L ^a  

^a FLORIDA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; FIBRIN; LIPOCORTIN 5; MEMBRANE PROTEIN; PENTOXIFYLLINE; PROCOAGULANT; THROMBOPLASTIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; BREAST CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; CELL HYPOXIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN DEPOSITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; LUNG CARCINOMA; LUNG METASTASIS; MELANOMA CELL; METASTASIS POTENTIAL; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUPERNATANT; THROMBOCYTOPENIA; TUMOR CELL;

ANIMALS; CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; FREE RADICAL SCAVENGERS; HUMANS; LYMPHOKINES; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PENTOXIFYLLINE; RATS; THROMBOPLASTIN; TUMOR CELLS, CULTURED; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031757127     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 1987; 57: 673-86.
2. Edwards RL, Silver J, Rickles FR. Human tumor procoagulants: Registry of the Subcommittee of Haemostasis of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis. Thromb Haemost 1993; 69: 205-13.
3. Herbert JM, Savi P, Laplace MC, Lale A. IL4 inhibits LPSinduced, IL1-betai-nduced and TNFalpha-induced expression of tissue factor in endothelial cells and monocytes. FEBS Lett 1992; 310: 31-3.
4. Walz DA , Fenton JW. The role of thrombin in tumor cell metastasis. Invasion Metastasis 1994; 14: 303-8.
5. Nagy JA, Brown LF, Senger DR, Lanir N, van de Water L, Dvorak AM, Dvorak HF. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1988; 948: 305-26.
6. Qi J, Kreutzer D. Fibrin activation of vascular endothelial cells: induction of IL8. Journal Of Immunology 1995; 155: 867-76.
7. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442-7.
8. Zhang Y, Deng Y, Luther T, Müller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994; 94: 1320-7.
9. Bromberg ME, Konigsberg WH, Madison J, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc. Natl. Acad. Sci. USA 1995; 92: 8205-9.
10. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996; 2: 209-15.
11. Shoji M, Abe K, Nawroth PP, Rickles FR. Molecular mechanisms linking thrombosis and angiogenesis in cancer. Trends In Cardiovascular Medicine 1997; 7: 529.
12. Ferrara N. Vascular Endothelial Growth Factor. Eur J Cancer 1996; 32A: 2413-22.
13. Shimizu S. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-X. Cancer Res 1996; 56: 2161-6.
14. Shweioki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis. Nature 1992; 359: 843-5.
15. Herbert JM, Corseaux D, Lale A, Bernat A. Hypoxia primes endotoxininduced tissue factor expression in human monocytes and endothelial cells by a PAFDependent mechanism. J Cell Physiol 1996; 169: 290-9.
16. Ramani M, Khechai F, Ollivier V, Ternisien C, Bridey F, Hakim J, de Prost D. Interleukin-10 and pentoxifylline inhibit Creactive proteininduced tissue factor gene expression in peripheral human blood monocytes. FEBS Lett 1994; 356: 86-8.
17. Deprost D. Pentoxifylline: A potential treatment for thrombosis associated with abnormal tissue factor expression by monocytes and endothelial cells. J Cardiovasc Pharmacol 1995; 25: S114-118.
18. Amirkhosravi A, Biggerstaff JP, Warnes G, Francis DA, Francis JL. Determination of tumor cell procoagulant activity by Sonoclot (TM) analysis in whole blood. Thromb Res 1996; 84: 323-32.
19. Bradford M. A rapid and sensitive method for the quantitation of of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976, 72: 248-54.
20. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992; 11: 23748.
21. Bick RL. Coagulation abnormalities in malignancy - a review. Semin Thromb Hemostasis 1992; 18: 353-72.
22. Zacharski LR, Memoli VA, Costantini V, Wojtukiewicz MZ, Ornstein DL. Clotting factors in tumour tissue: implications for cancer therapy. Blood Coagul Fibrinolysis 1990; 1: 718.
23. Dvorak HF, Senger DR, Dvorak AM. Fibrin as a component of the tumour stroma: origins and biological significance. Cancer Metast Rev 1983; 2: 4173.
24. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease. Nature Med 1996; 2: 209-15.
25. Yan SF, Gao Y, Zhai C, Oeth P, Mackman N. Hypoxia-induced expression of tissue factor is mediated by the Transcription Factor EGR1. Circulation 1997; 96: I662.
26. Amirkhosravi M, Francis JL. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation, Thromb Haemost 1995; 73: 59-65.
27. Leclerc NE, HaanArchipoff G, Lenoble M, Beretz A. Inhibitors of phosphodiesterase (pentoxifylline, trequinsin) inhibit apical and subcellular matrix expression of tissue factor in cultured human endothelial cells. J Cardiovasc Pharmacol 1995; 25: S88-91.
28. Su SJ, Chang KL, Lin TM, Huang YH, Yeh TM. Uromodulin and TammHorsfall protein induce human monocytes to secrete TNF and express tissue factor. Immunology 1997; 158: 3449-56.
29. Amirkhosravi A, Warnes G, Biggerstaff J, Malik Z, May K, Francis JL. The effect of pentoxifylline on spontaneous and experimental metastasis of the mouse Neuro2a neuroblastoma. Clin Expl Metastasis 1997; 15: 453-61.
30. Melnyk O, Shuman MA, Kim KJ. Vascular Endothelial Growth Factor Promotes Tumors Dissemination by a Mechanism Distinct from Its Effect on Primary Tumor Growth. Cancer Res 1996; 56: 921-4.
31. Mazure NM, Chen EY, Laderoute KR and Giaccia AJ. Induction of Vascular Endothelial Growth Factor by Hypoxia Is Modulated by a Phosphatidylinositol 3-Kinase/Akt Signalling Pathway in Ha-ras-Transformed Cells Through a Hypoxia Inducible Factor-1 Transcriptional Element. Blood 1997; 90: 3322-31.
32. Clauss M, Grell M, Fangmann C, Fiers W, Scheurich P, Risau W. Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: Functional analysis of the tumor necrosis factor receptors. FEBS Lett 1996; 390: 3348.
33. Ollivier V, Bentolila S. Chabbat J, Hakim J and de Prost D. Tissue Factor-Dependent Vascular Endothelial Growth Factor Production by Human Fibroblasts in Response to Activated Factor VII. Blood 1998; 91: 2698-703.
34. Mueller BM and Ruf W. Requirement for binding of catalytically active factor Vila in tissue factor-dependent experimental metastasis. J. Clin. Invest. 1998; 7: 1372-8.
35. Pepper MS, Mandriota SJ, Vassalli JD, Orci L, Montesano R. Angiogenesis regulating cytokines: activities and interactions. Curr Top Microbiol Immunol 1996; 213: 31-67.
36. Pepper MS. Manipulating angiogenesis - From basic science to the bedside. Arterioscler Thromb Vase Biol. 1997; 17: 605-19.
37. Risau W.What, if anything, is an angiogenic factor? Cancer Metast Rev 1996; 15: 149-51.
38. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YCE, Olander JV, Connolly DT, Stern D.Vascularpermeability factor - a tumor-derived polypeptide that induces endothelialcell and monocyte procoagulant activity, and promotes monocyte migration. Experimental Medicine 1990; 172: 1535-45.